Table 1.
Characteristics of prostate cancer case patients (n = 1260)*
| Characteristic | Case patients |
| Age at blood collection (y), mean (SD) | 64.4 (7.8) |
| Age at diagnosis (y), mean (SD) | 69.5 (7.5) |
| Stage, No. (%)† | |
| T1, T2 (N0, M0) | 1010 (86) |
| T3a (N0, M0) | 92 (8) |
| T3b (N0, M0) | 43 (4) |
| T4 (N0, M0) | 1 (0) |
| N1 | 15 (1) |
| M1 | 15 (1) |
| Gleason grade, No. (%)‡ | |
| 2 to 6 | 646 (56) |
| 7: 3 + 4 or no major score defined | 275 (24) |
| 7: 4 + 3 | 110 (9) |
| 8 to 10 | 129 (11) |
| Deaths or metastases due to prostate cancer, No. (%) | 114 (9) |
| Prostate cancer deaths without recorded date of metastasis | 68 |
| Metastases to bone or organs on follow-up | 31 |
| Metastases at diagnosis | 15 |
| Time to diagnosis from blood draw (y), median (IQR) | 5.2 (2.9–7.5) |
| Time to lethal prostate cancer (death or metastases) from diagnosis (y), median (IQR) | 5.2 (3.1–8.4) |
IQR = interquartile range; SD = standard deviation.
Data for stage missing for 84 subjects.
Data for Gleason grade missing for 100 subjects.